Irene Possenti

Irene Possenti

Auto-generated profile, based on publicly available information

Irene Possenti

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2024 in Gastric Cancer
Verified
Journal Article
Closed access
PDF file
Matteo RotaMatteo Rota
Matteo Rota
IPIrene Possenti
Irene Possenti
VVValeria Valsassina
Valeria Valsassina
CSClaudia Santucci
Claudia Santucci
VBVincenzo Bagnardi
Vincenzo Bagnardi
ALAlessandra Lugo
Alessandra Lugo

1 October 2024 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
IPIrene Possenti
Irene Possenti
MRMarco Romelli
Marco Romelli
GCGiulia Carreras
Giulia Carreras
ABAnnalisa Biffi
Annalisa Biffi
VBVincenzo Bagnardi
Vincenzo Bagnardi
ALAlessandra Lugo
Alessandra Lugo
Background: Lung cancer ranks as the leading cause of cancer-related deaths worldwide. There is evidence that second-hand smoke (SHS) exposure is a risk factor for the development of lung cancer in never-smokers. This systematic review and meta-analysis aims to provide the most accurate quantification of the association between SHS exposure and lung cancer risk in never-smokers.Materials and methods: Through the use of an innovative method to identify original publications, we conducted a systematic review of the literature, with corresponding meta-analysis, of all epidemiological studies evaluating the association between SHS exposure and lung cancer risk among never-smokers, published up to May 2023. Pooled relative risks were obtained using random-effects models. Dose–response relationships were derived using log-linear functions or cubic splines.Results: Out of 126 identified eligible studies, 97 original articles were included in the meta-analysis. The pooled relative risk for lung cancer for overall exposure to SHS was 1.24 (95% CI 1.16–1.32, number of articles, n=82). Setting-specific relative risks were 1.20 (95% CI 1.12–1.28, n=67) for SHS exposure at home, 1.38 (95% CI 1.28–1.62, n=30) at a workplace, 1.37 (95% CI 1.22–1.53, n=28) at home or a workplace and 1.27 (95% CI 1.11–1.44, n=24) in nonspecified settings. The risk of lung cancer significantly increased with the duration, intensity and pack-years of SHS exposure.Conclusions: This meta-analysis shows that exposure to SHS increases by more than 20% the risk of lung cancer among never-smokers, providing definitive evidence of the association between SHS exposure and lung cancer risk.

5 December 2023 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
MSMarco Scala
Marco Scala
Cristina BosettiCristina Bosetti
Cristina Bosetti
VBVincenzo Bagnardi
Vincenzo Bagnardi
IPIrene Possenti
Irene Possenti
CSClaudia Specchia
Claudia Specchia
ALAlessandra Lugo
Alessandra Lugo
BackgroundThe possible association between cigarette smoking and breast cancer risk has been quite controversial.MethodsWe conducted a systematic review and meta-analysis of all available observational studies published on the issue up to January 2020. Random-effects models were used to compute pooled relative risks (RRs) for cigarette smoking status and dose-risk relationships were evaluated using one-stage random-effects dose-response models.ResultsA total of 169 studies were selected, providing a pooled RR for breast cancer of 1.07 (95% confidence interval, CI, 1.05-1.10) for current, 1.08 (95% CI 1.06-1.10) for former, and 1.09 (95% CI 1.07-1.11) for ever smokers, compared to never smokers. Results were consistent in case-control and cohort studies. No meaningful differences were observed across strata of most covariates considered, nor according to relevant genetic mutations and polymorphisms (i.e., BRCA mutation, N-acetyltransferase and glutathione S-transferase genotypes, and P53). Breast cancer risk increased linearly with intensity of smoking (RR 1.12, 95% CI 1.08-1.16, for 20 and 1.26, 95% CI 1.17-1.36 for 40 cigarettes/day), and with increasing duration of smoking (RR 1.05, 95% CI 1.03-1.08, for 20 and 1.11, 95% CI 1.06-1.16, for 40 years of smoking).ConclusionsThe present large and comprehensive meta-analysis – conducted using an innovative approach for study search – supports the evidence of causal role of tobacco smoking on breast cancer risk.

28 June 2024 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
IPIrene Possenti
Irene Possenti
MSMarco Scala
Marco Scala
GCGiulia Carreras
Giulia Carreras
VBVincenzo Bagnardi
Vincenzo Bagnardi
Cristina BosettiCristina Bosetti
Cristina Bosetti
ALAlessandra Lugo
Alessandra Lugo

21 October 2024 in Tobacco Prevention & Cessation
Verified
Journal Article
Open access
IPIrene Possenti
Irene Possenti
Silvano GallusSilvano Gallus
Silvano Gallus
ALAlessandra Lugo
Alessandra Lugo
ALAnna Mar López
Anna Mar López
GCGiulia Carreras
Giulia Carreras
EFEsteve Fernández
Esteve Fernández
Exposure to secondhand tobacco smoke (SHS) is a global health threat that causes diseases and kills more than 1.2 million people each year, including 65000 children1-4. The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) urges countries to establish comprehensive...

3 June 2024 in Tobacco Induced Diseases
Verified
Journal Article
Open access
IPIrene Possenti
Irene Possenti
MSMarco Scala
Marco Scala
MRMagda Rognoni
Magda Rognoni
ALAlessandra Lugo
Alessandra Lugo
MCMaria Sofia Cattaruzza
Maria Sofia Cattaruzza
LDLuca Cavalieri D'Oro
Luca Cavalieri D'Oro
Introduction: Tobacco-related diseases have a substantial economic impact in terms of medical expenses, loss of productivity, and premature death. Tobacco use is estimated to be responsible for more than 90000 deaths each year in Italy. We aimed to evaluate the annual direct economic impact on...